Medical Devices & Pharma: FDA 21 CFR Part 11 & FEFO Traceability
An enterprise engineering blueprint for managing FDA 21 CFR Part 11 e-signatures, DSCSA track-and-trace serialization, quality quarantine holds, and cold-chain FEFO picking in Microsoft Dynamics 365 Business Central.
1. Executive Summary & Life Sciences Compliance Risk
Pharmaceutical manufacturers and medical device distributors operate under strict regulatory scrutiny. Non-compliance with FDA 21 CFR Part 11 (Electronic Signatures) or DSCSA (Drug Supply Chain Security Act) track-and-trace requirements risks warning letters, product seizures, or severe financial penalties.
In Microsoft Dynamics 365 Business Central, deploying Dual E-Signature Validation Codeunits and Quarantine Status Inventory Controls ensures total regulatory audit readiness.
2. FDA 21 CFR Part 11 Electronic Signature Architecture
FDA 21 CFR Part 11 mandates that electronic records and signatures possess the same legal weight as paper records.
3. Production AL Code: Dual E-Signature & Quality Release Engine
Below is a production AL Codeunit enforcing dual authentication and immutable audit logging for pharmaceutical batch release:
4. DSCSA Serialization & 2D Barcode Track-and-Trace
Tracking 2D DataMatrix barcodes containing NDC, Serial Number, Lot Number, and Expiration Date across all warehouse movement steps.
5. Quarantine Inventory Holds & Certificate of Analysis (CoA)
Incoming raw materials are automatically placed in QUARANTINE inventory status until laboratory testing passes and a Certificate of Analysis (CoA) PDF is attached to the Lot record.
6. Measurable Compliance Security & ROI
Need Expert Technical Guidance?
Consult directly with DataDaur's Senior ERP Architects & AI Engineers for custom architecture reviews, migration strategies, or technical audits.